益華控股(02213.HK)因欠款接獲清盤呈請
格隆匯5月26日丨益華控股(02213.HK)公佈,於2020年5月26日,公司收到一名獨立人士在香港特別行政區高等法院原訟法庭針對公司提出日期為2020年5月25日的呈請。根據該呈請,呈請人呈請根據香港法例第32章《公司(清盤及雜項條文)條例》的條文將公司清盤的命令。
呈請人指稱,公司於2020年4月9日欠呈請人一筆為數311萬港元的款項,該筆款項包括公司尚未償還債券本金總額300萬港元、應計利息105,000港元及法律費用3,000港元的一部分。
該呈請將於2020年8月19日上午9時30分在香港特別行政區高等法院原訟法庭展開聆訊。公司正在就該呈請尋求法律意見並與呈請人磋商和解。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.